Compounds > 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
Page last updated: 2024-09-03

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Cataract, Membranous

4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Cataract, Membranous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, Y; Tsutsumi, K; Yoshida, C1

Other Studies

1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Cataract, Membranous

ArticleYear
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:12

    Topics: Animals; Benzamides; Blood Glucose; Cataract; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Enzyme Activation; Hyperlipidemias; Lipids; Lipoprotein Lipase; Male; Organophosphorus Compounds; Rats; Rats, Wistar; Risk Factors

1996